# Investigation of the Metabolism and Pharmacokinetics of Ambroxol in Healthy Male Volunteers

> **NCT02194257** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C]-cyclohexane ambroxol oral solution
- **DRUG:** [14C]-benzyl ambroxol oral solution
- **DRUG:** Ambroxol lozenge

## Key facts

- **NCT ID:** NCT02194257
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2008-12
- **Final completion:** —
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02194257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02194257, "Investigation of the Metabolism and Pharmacokinetics of Ambroxol in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02194257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*